Siyi Intelligence Secures Nearly RMB 100 Million Series A Funding to Build a Professional Rehabilitation Robotics Portfolio

VCBeat learned第一时间 that SIYI INTELLIGENCE is the leading company in the field of soft rehabilitation robots in China.SIYI INTELLIGENCEAnnouncement CompletedNearly 100 million yuanofRound AFinancing. This round was led byGuosheng CapitalLeading investment, original investorsDA CapitalContinue to follow up. The funds raised will be used to accelerate SIYI INTELLIGENCE's innovative R&D in integrated solutions for the neurorehabilitation field and to build a digital rehabilitation service platform.

SIYI INTELLIGENCE, founded in 2017, is a national high-tech enterprise specializing in providing intelligent products and innovative services for professional rehabilitation in hospitals, communities, and families. The company is committed to overcoming core technologies in the field of rehabilitation robotics, and through the intelligent transformation and digital upgrade of the rehabilitation industry, it aims to create an integrated rehabilitation solution featuring "smart hardware + services + AI technology." This solution breaks down technical and information barriers across the entire rehabilitation cycle in hospitals, communities, and homes, realizing the vision of everyone having access to innovative rehabilitation services.

SIYI INTELLIGENCE is an innovative rehabilitation technology company comprised of a team of doctors and masters from the University of Electronic Science and Technology, Harbin Institute of Technology, Shanghai Jiao Tong University, and Jilin University. It is committed to creating world-leading professional rehabilitation robots. The core members all have more than ten years of experience in the robotics and rehabilitation medical industries, operating under a dual-headquarters model with Shanghai and Chengdu as the core locations.

SIYI INTELLIGENCE integrates multidisciplinary professional knowledge and technology to create a series of professional-grade rehabilitation robots for academic research, clinical applications, and home use. They have successively developed globally leading brain-computer interface soft robotic hand function rehabilitation robots, EasyWalk, the first lower limb soft exoskeleton in China, and other hardcore technology products such as the first upper limb rehabilitation robot in China that can simultaneously meet the rehabilitation needs of hospitals, communities, and families.

In order to accelerate the implementation and verification of clinical rehabilitation theories, an integrated "industry-university-research-medicine" ecosystem has been established. In-depth collaborations have been carried out successively with internationally renowned institutions such as Shanghai Jiao Tong University, Shanghai University of Traditional Chinese Medicine, Huashan Hospital Affiliated to Fudan University, West China Hospital of Sichuan University, Tohoku University in Japan, Royal Buckinghamshire Hospital in the UK, and Hobbs Rehabilitation Center in the UK.

The collaborative innovation of industry-university-research-medical sectors continues to inject momentum into SIYI INTELLIGENCE's innovation. By 2022, the company has applied for nearly 100 patents and carried out global intellectual property layout, owning more than 30 authorized patents, over 50 registered trademarks, and more than 10 software copyrights.

Currently, China's rehabilitation industry is still in its infancy. At the patient level, there is still a prevailing mindset that prioritizes treatment over rehabilitation. In terms of medical resources, there is a severe shortage of professional rehabilitation therapists, insufficient rehabilitation beds in hospitals, a lack of professional rehabilitation equipment, and inadequate development of rehabilitation processes. For out-of-hospital rehabilitation, communities and families lack effective rehabilitation methods, preventing patients from accessing professional and comprehensive rehabilitation services… With the intensification of aging, rehabilitation issues are becoming increasingly prominent, and the billion-dollar rehabilitation market urgently needs more efficient, intelligent, and accessible solutions.

The Yisheng Hand Function Rehabilitation Robot series is the flagship product of SIYI INTELLIGENCE. Based on soft robotics technology and neuroscience theory, compared to other rehabilitation robots with single, mechanical fixed movements, SIYI INTELLIGENCE's soft hand function rehabilitation robot integrates soft pneumatic robot technology, electromyography technology, and artificial intelligence technology. Utilizing the rich physiological information characteristics of electromyographic signals, it can instantly perceive and recognize the user's movement intentions, assisting users in safe, effective, and comprehensive active rehabilitation, improving rehabilitation efficiency and outcomes. Currently, the Yisheng Hand Function Rehabilitation Robot has entered more than 80 countries and regions in China, been implemented in over 3,000 medical institutions, benefited more than 50,000 families, and achieved scaled application in both clinical and home settings.

Brain-Computer Interface as a Communication Technology: Under Conditions Without Relying on Any Muscles or Neuromuscular Pathways, It Enables Electrical Signals to Be Directly Transmitted from Neurons to External Devices or Systems to Achieve Collaborative Cooperation Between the Brain and Devices. SIYI INTELLIGENCE Has Developed the World’s Leading Brain-Computer Interface Hand Function Rehabilitation Robot (Brain-Computer Interface Rehabilitation Training and Evaluation System). Its Principle Is to Stimulate Patients’ Active Movement Awareness Through Brain-Controlled Rehabilitation Training, Achieving "Perception-Control" Bidirectional Closed-Loop Neural Stimulation, Remodeling Patients’ Neural Pathways, and Enhancing Rehabilitation Efficacy. It Has Already Been Applied in Hospitals.

SIYI INTELLIGENCE has taken an early lead in the exoskeleton field, launching China’s first lower-limb soft exoskeleton two years ago. This product combines bionic structural design with artificial intelligence control algorithms, avoiding the mechanically rigid movement patterns of traditional rigid exoskeletons that force users into walking. At the same time, the AI algorithm can adapt to the wearer's needs and provide optimized assistance strategies. EasyWalk not only represents a major technological innovation but also brings the price down to the ten-thousand-yuan level, truly achieving consumer-grade accessibility. It can better meet the needs of home and community rehabilitation, helping patients move out of their homes, integrate into the community, and embrace life.

Due to the full-cycle and multi-scenario nature of rehabilitation, SIYI INTELLIGENCE's focus is not limited to the hospital end. SIYI INTELLIGENCE believes that in the future, homes and communities will become the core scenarios for rehabilitation, and the market urgently needs more professional, convenient, and cost-effective rehabilitation robot products.

Relying on the professional product technology accumulation for hospitals, SIYI INTELLIGENCE has formed an integrated intelligent rehabilitation solution standardized for three scenarios: hospital, community, and home, closely focusing on the entire rehabilitation cycle of patients both inside and outside the hospital.

To address the challenges of providing remote rehabilitation services and the difficulty in real-time feedback and analysis of full-cycle information, SIYI INTELLIGENCE has developed an integrated rehabilitation solution based on IoT technology. By collecting and analyzing data from intelligent rehabilitation devices used by patients across different scenarios such as hospitals, communities, and homes, the company has built a digital rehabilitation service platform. This platform focuses on core functions such as telemedicine and information exchange, compliance management, and home rehabilitation guidance, offering patients more professional rehabilitation services and ultimately achieving better rehabilitation outcomes.

Since its establishment, SIYI INTELLIGENCE has adhered to innovation and pursued long-term goals. In 2022, it began to make a name for itself in various competitions——

• SIYI INTELLIGENCE Participates in the Development of the Industry Standard "Electromagnetic Compatibility Requirements and Test Methods for Rehabilitation Training Robots" Officially Released and Implemented;

• The company was featured in CCTV's special report on "New Measures for Elderly Care in the 14th Five-Year Plan";

• Yin Ganggang, founder and general manager of SIYI INTELLIGENCE, has been honored with the "Rising Star of the Year in China's Robotics Industry Award";

• Awarded the "Second Prize of China Industry-University-Research Cooperation Innovation Achievement Award" of the 2021 China Industry-University-Research Cooperation Innovation and Promotion Award

• Products of the company have been selected into the "Shanghai Smart Health Elderly Care Products and Services Promotion Catalog (2022 Edition)";

• Company Product Brain-Computer Interface Soft Robotic Hand Function Robot Awarded CMEF "Top 10 Innovative Technology Products of 2022";

• ……

In the future, SIYI INTELLIGENCE will continue to make rapid progress in the field of rehabilitation robots, moving forward on the "Yi" path, exploring and building a "comprehensive rehabilitation" ecosystem, and creating a globally leading professional rehabilitation robot portfolio for the comprehensive rehabilitation field.

For this round of financing,Yin Ganggang, Founder and General Manager of SIYI INTELLIGENCEStated: "We are very grateful for the investors' recognition of our work. As an innovative R&D enterprise specializing in rehabilitation robotics, we are deeply aware of the multiple profound social issues within the rehabilitation industry, such as the shortage of medical resources, severe insufficiency of rehabilitation resources at the community and family levels, and the accelerating aging population. With the passion and sincerity to ensure ‘everyone can access innovative rehabilitation services,’ we gladly embrace the challenges bestowed upon us by the industry and the times. We are committed to creating professional-grade rehabilitation robots that are affordable and accessible to the general public. Fortunately, our products have already entered more than 3,000 medical institutions, serving over 80 countries and millions of users worldwide. Equally fortunate is that we have encountered like-minded investors in the field of rehabilitation who support us in accelerating innovation and R&D in integrated solutions for neurological rehabilitation and building a digital rehabilitation service platform, collectively advancing the rehabilitation industry toward a more brilliant future."

Chengdu Guosheng Capital Investment TeamStated: "SIYI INTELLIGENCE has a versatile team with extensive experience in rehabilitation and technology, demonstrating a deep understanding of the industry. The company boasts numerous patents in the technical field and its products have already reached a wide market. This is an enterprise with extremely strong innovation capabilities and a high level of industrialization. We look forward to SIYI INTELLIGENCE launching more innovative rehabilitation products soon, providing rehabilitation patients with a broader range of choices and higher quality services."

Chairman of Daoyuan Capital, Zhang DafengStated: "SIYI INTELLIGENCE has taken hand function rehabilitation services as the entry point, continuously extending its product line and innovating rehabilitation services. The integrated smart rehabilitation platform it has built, covering the entire rehabilitation cycle for hospitals, communities, and home use, is highly distinctive and offers industry differentiation. Therefore, we firmly believe in SIYI INTELLIGENCE and have consistently invested in every round. China's rehabilitation system is undergoing a transformation, and SIYI INTELLIGENCE has emerged as a new force in the rehabilitation field with its dual innovation in technology and business models. In the future, we look forward to exploring a better new future for the rehabilitation industry together with SIYI INTELLIGENCE and creating even greater social value."

Guosheng Capital is a state-owned industrial capital rooted in Chengdu Tianfu International Bio City, serving the development of innovative life sciences globally. It has formed a cluster of nine industry-linked parent-child funds with a total scale of 10 billion yuan. It has completed investments in nearly 70 outstanding companies in the biopharmaceutical field, covering five major areas: modern biotechnology drugs, chemical innovative drugs, high-performance medical devices, professional outsourcing services, and health services. Its industrial cultivation achievements are remarkable, including 2 listed companies, 4 unicorn enterprises, and several "specialized, refined, distinctive, and innovative" enterprises. Guosheng Capital has been honored as one of the top 10 best new VC investment institutions in China by CVCRI in 2021, one of the top 10 most potential venture capital institutions in China by CVSource in 2021, and received the 2022 Chengdu New Economy Venture Capital Outstanding Contribution Award. Following the principle of government guidance + market logic + professional operation, it is committed to becoming the most influential comprehensive financial service provider in the industry in China.

Daoyuan Capital is a leading private equity investment institution focused on the healthcare sector, dedicated to helping outstanding healthcare companies grow rapidly through the power of capital and industry resources. It aims to provide society with better medical products and services, thereby improving human health. Currently, Daoyuan Capital manages 15 RMB funds and 3 USD funds. Its funds have invested in 83 outstanding projects, including 14 IPOs such as Jinxin Fertility (01951.HK), Viva Biotech (01873.HK), Sinno Medical (688108.SH), Anbiping (688393.SH), and Clover Biopharmaceuticals (02197.HK). As of the latest date in 2023, one company has received approval from the CSRC for registration on the ChiNext Board, one has passed the review of the STAR Market Listing Committee, and another has passed the listing hearing of the Hong Kong Stock Exchange. It is expected that over the next two years, more than 10 of Daoyuan Capital's portfolio companies will go public on major stock exchanges at home and abroad.

SIYI INTELLIGENCE is a global company that specializes in providing innovative rehabilitation products and services for hospitals, communities, and families. It is committed to creating world-leading professional rehabilitation robots, making innovative rehabilitation services accessible to everyone. Upholding the principles of innovation, excellence, professionalism, and internationalization, the company has established production, research, and operational bases in Shanghai and Chengdu, China, and is building a global marketing network. Its brands, such as Eijia® and SYREBO®, have gained widespread acclaim. The company has launched a series of products, including hand function rehabilitation robots, lower limb soft exoskeletons, and upper limb rehabilitation robots. These products have obtained Class II medical device registration certificates and received multiple authoritative certifications, such as China NMPA, U.S. FDA, and EU CE. They have entered more than 80 countries and regions, over 3,000 medical institutions, and more than 50,000 households, serving millions of people worldwide.